Antimicrobials: The Year in Review

News
Article

This year saw the approval of new therapies as well as the continued evolution of time-to-treat infections and updated guidelines.

Recent Videos
Related Content
European CDC: Carbapenem Resistant Enterobacterales Poses a Significant Threat

European CDC: Carbapenem Resistant Enterobacterales Poses a Significant Threat

John Parkinson
February 4th 2025
Article
From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc ;Jose Alexander, MD, ABMM, ABAIM, FCCM, CIC, ASCP, BCMAS
December 23rd 2024
Podcast
Levofloxacin Protects TB Contacts in Meta-Analysis but not RCTs

Levofloxacin Protects TB Contacts in Meta-Analysis but not RCTs

Kenneth Bender, PharmD, MA
February 4th 2025
Article
The Latest Updates on Managing Your Patients With Antimicrobial Resistant Gram-Negative Infections

The Latest Updates on Managing Your Patients With Antimicrobial Resistant Gram-Negative Infections

Christian Sandrock, MD, MPH, FCCP
November 8th 2023
Podcast
Challenges and Implications of the V Quinn TB Prevention Trial

Challenges and Implications of the V Quinn TB Prevention Trial

Sophia Abene;Gregory Fox, PhD, MIPH, FRACP, MBBS, BSc(Med), GAICD
January 31st 2025
Article
Levofloxacin for Preventing Multidrug-Resistant Tuberculosis

Levofloxacin for Preventing Multidrug-Resistant Tuberculosis

Sophia Abene;Gregory Fox, PhD, MIPH, FRACP, MBBS, BSc(Med), GAICD
January 30th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.